George Institute for Global Health Apr 22 2026 Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of another stroke in patients with intracerebral hemorrhage and high blood pressure. Results from the TRIDENT randomized controlled trial, led by The George Institute for Global Health, were published today in The New England Journal of Medicine . Professor Craig Anderson, Principal Investigator and Senior Professorial Fellow